Caseware UK (AP4) 2023.0.135 2023.0.135 2023-03-31No description of principal activityfalse1The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false1true2022-04-01false 11882707 2022-04-01 2023-03-31 11882707 2021-04-01 2022-03-31 11882707 2023-03-31 11882707 2022-03-31 11882707 c:Director1 2022-04-01 2023-03-31 11882707 c:RegisteredOffice 2022-04-01 2023-03-31 11882707 d:CurrentFinancialInstruments 2023-03-31 11882707 d:CurrentFinancialInstruments 2022-03-31 11882707 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 11882707 d:CurrentFinancialInstruments d:WithinOneYear 2022-03-31 11882707 d:RetainedEarningsAccumulatedLosses 2023-03-31 11882707 d:RetainedEarningsAccumulatedLosses 2022-03-31 11882707 c:FRS102 2022-04-01 2023-03-31 11882707 c:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 11882707 c:FullAccounts 2022-04-01 2023-03-31 11882707 c:CompanyLimitedByGuarantee 2022-04-01 2023-03-31 11882707 e:PoundSterling 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure
Registered number: 11882707










ELEXIAL RESEARCH LIMITED

(A company limited by guarantee)
UNAUDITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023




















 
ELEXIAL RESEARCH LIMITED
 
(A company limited by guarantee)
 
 
Company Information


Director
E Hennings 




Registered number
11882707



Registered office
International House
223 Regent Street

6th Floor

London

England

W1B 2QD





 
ELEXIAL RESEARCH LIMITED
 
(A company limited by guarantee)
Registered number: 11882707

Balance sheet
As at 31 March 2023

2023
2022
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
-
7,068

  
-
7,068

Creditors: amounts falling due within one year
 5 
(106,529)
(110,810)

Net current liabilities
  
 
 
(106,529)
 
 
(103,742)

Total assets less current liabilities
  
(106,529)
(103,742)

  

Net liabilities
  
(106,529)
(103,742)


Capital and reserves
  

Profit and loss account
  
(106,529)
(103,742)

  
(106,529)
(103,742)


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 23 September 2024.




E Hennings
Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
ELEXIAL RESEARCH LIMITED

(A company limited by guarantee)
 
 
 
Notes to the financial statements
For the Year Ended 31 March 2023

1.


General information

Elexial Research Limited is a private limited company, incorporated in the United Kingdom and registered in England and Wales. The company's registered office address International House, 223 Regent Street, 6th Floor, London, England, W1B 2QD.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Going concern

The accounts have been prepared on a going concern basis despite an excess of liabilities over total assets. The director considers this appropriate as Boston Medical Group Spain SLU, a company under common control, has agreed to support the company for at least the next twelve months from the date of approval of these financial statements.

 
2.3

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.4

Creditors

Short term creditors are measured at the transaction price. 

 
2.5

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Page 2

 
ELEXIAL RESEARCH LIMITED

(A company limited by guarantee)
 
 
 
Notes to the financial statements
For the Year Ended 31 March 2023

2.Accounting policies (continued)


2.5
Financial instruments (continued)

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.
 
Page 3

 
ELEXIAL RESEARCH LIMITED

(A company limited by guarantee)
 
 
 
Notes to the financial statements
For the Year Ended 31 March 2023

2.Accounting policies (continued)


2.5
Financial instruments (continued)

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

 
2.6

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


3.


Employees




The average monthly number of employees, including directors, during the year was 1 (2022 - 1).

Page 4

 
ELEXIAL RESEARCH LIMITED

(A company limited by guarantee)
 
 
 
Notes to the financial statements
For the Year Ended 31 March 2023

4.


Debtors

2023
2022
£
£


Other debtors
-
7,024

Prepayments
-
44

-
7,068



5.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
3,216
2,340

Other creditors
101,213
105,896

Accruals
2,100
2,574

106,529
110,810



6.


Company status

The company is a private company limited by guarantee and consequently does not have share capital.
The member has confirmed that if the company is wound up whilst they are a member, or within one year after they cease to be a member, they will contribute to the assets of the company by such amount as may be required for:

payments of debts and liabilities of the company contracted before they cease to be a member;
payments of costs, charges and expenses of winding up, and;
adjustment of the rights of the contributors among ourselves, not exceeding £1.

 
Page 5